Trinity Biotech | TRIB - Assets


Trinity Biotech reported $103.71M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
EDAP TMS EUR 61.46M 6.88M Sep/2025
J&J USD 200.89B 1.68B Mar/2026
Mesa Laboratories USD 434.85M 4.5M Dec/2025
OraSure Technologies USD 403.17M 19.93M Dec/2025
Plus Therapeutics USD 16.32M 2.34M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Siemens EUR 170.13B 3.93B Dec/2025
Surmodics USD 169.82M 8.74M Jun/2025
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Tosoh JPY 1.34T 44.3B Dec/2025
Trinity Biotech USD 103.71M 4.08M Sep/2025
Veracyte USD 1.41B 38.23M Dec/2025